(PSTV) Plus Therapeutics - Performance -69.4% in 12m
Compare PSTV with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
-92.30%
#184 in Group
Rel. Strength
6.95%
#7404 in Universe
Total Return 12m
-69.44%
#131 in Group
Total Return 5y
-97.33%
#165 in Group
P/E -
(?) Percentile in Group
P/E Forward -
(?) Percentile in Group
PEG -
(?) Percentile in Group
FCF Yield -
(?) Percentile in Group
12m Total Return: PSTV (-69.4%) vs XBI (-14.9%)

5y Drawdown (Underwater) Chart

Top Performers in Biotechnology
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
---|---|---|---|---|---|---|---|---|
UTHR NASDAQ United Therapeutics |
7.21% | 14% | 161% | 12.1 | 11 | 1.43 | 74.6% | 16.1% |
HLN NYSE Haleon |
7.98% | 32.4% | 49.3% | 24.4 | 20.2 | 1.79 | 69.1% | 13.6% |
AMGN NASDAQ Amgen |
-7.04% | -11.2% | 27.7% | 25.5 | 13.5 | 0.95 | 0.60% | 41% |
LONN SW Lonza |
11.7% | 13.3% | 33.5% | 67.1 | 35.1 | 1.28 | 2.20% | -12.5% |
BIM PA Biomerieux |
2.2% | 21% | -1.63% | 32.5 | 25.2 | 1.52 | -38.5% | -25.1% |
KMDA NASDAQ Kamada |
13.3% | 27.1% | -5.64% | 27.5 | 25.1 | 1 | 32.5% | 3.93% |
NBIX NASDAQ Neurocrine Biosciences |
27.3% | -15% | 1.88% | 32.3 | 21.6 | 0.27 | 68.0% | 31.9% |
ERF PA Eurofins Scientific SE |
20% | 0.38% | 8.05% | 26.6 | 13.6 | 0.56 | -66.6% | -17.1% |
Performance Comparison: PSTV vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for PSTV
Total Return (including Dividends) | PSTV | XBI | S&P 500 |
---|---|---|---|
1 Month | -12.00% | 2.77% | 5.69% |
3 Months | -46.34% | -14.21% | -6.49% |
12 Months | -69.44% | -14.88% | 9.72% |
5 Years | -97.33% | -26.47% | 107.51% |
Trend Score (consistency of price movement) | PSTV | XBI | S&P 500 |
1 Month | -40.9% | 57% | 89.4% |
3 Months | -48.7% | -82.3% | -72% |
12 Months | -89.8% | -53.1% | 49.3% |
5 Years | -96.2% | -53.9% | 84.1% |
Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
1 Month | #196 | -14.4% | -16.7% |
3 Month | #187 | -37.5% | -42.6% |
12 Month | #132 | -64.1% | -72.2% |
5 Years | #166 | -96.4% | -98.7% |
FAQs
Does PSTV Plus Therapeutics outperforms the market?
No,
over the last 12 months PSTV made -69.44%, while its related Sector, the SPDR S&P Biotech (XBI) made -14.88%.
Over the last 3 months PSTV made -46.34%, while XBI made -14.21%.
Over the last 3 months PSTV made -46.34%, while XBI made -14.21%.
Performance Comparison PSTV vs Indeces and Sectors
PSTV vs. Indices PSTV is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
US S&P 500 | SPY | 6.30% | -17.7% | -39.4% | -79.2% |
US NASDAQ 100 | QQQ | 6.03% | -19.4% | -39.8% | -80.2% |
US Dow Jones Industrial 30 | DIA | 6.41% | -14.7% | -38.4% | -75.7% |
German DAX 40 | DAX | 5.85% | -27.1% | -65.0% | -94.3% |
Shanghai Shenzhen CSI 300 | CSI 300 | 6.07% | -14.9% | -38.6% | -75.8% |
Hongkong Hang Seng | HSI | 3.42% | -26.9% | -48.9% | -77.7% |
India NIFTY 50 | INDA | 10.0% | -15.2% | -41.3% | -71.5% |
Brasil Bovespa | EWZ | 3.27% | -23.6% | -48.6% | -63.2% |
PSTV vs. Sectors PSTV is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
Communication Services | XLC | 6.93% | -18.5% | -45.6% | -89.8% |
Consumer Discretionary | XLY | 4.88% | -18.7% | -37.2% | -84.3% |
Consumer Staples | XLP | 7.16% | -12.7% | -46.3% | -76.7% |
Energy | XLE | 4.05% | -16.5% | -33.4% | -60.4% |
Financial | XLF | 5.60% | -18.8% | -45.3% | -91.0% |
Health Care | XLV | 10.4% | -8.94% | -34.2% | -63.4% |
Industrial | XLI | 5.37% | -20.3% | -40.4% | -79.8% |
Materials | XLB | 6.14% | -17.0% | -35.3% | -63.4% |
Real Estate | XLRE | 7.09% | -18.9% | -41.8% | -83.0% |
Technology | XLK | 5.46% | -21.7% | -37.1% | -75.5% |
Utilities | XLU | 5.58% | -17.1% | -47.2% | -85.5% |
Aerospace & Defense | XAR | 6.12% | -21.2% | -48.7% | -95.4% |
Biotech | XBI | 14.0% | -14.8% | -18.3% | -54.6% |
Homebuilder | XHB | 6.66% | -17.6% | -25.8% | -60.6% |
Retail | XRT | 6.24% | -18.1% | -33.1% | -63.2% |